Gland Pharma Releases Unaudited Q2 and Half Year FY27 Financial Results
Board approved results for period ending September 30, 2026, reviewed by Deloitte Haskins & Sells and posted on official platforms
Gland Pharma Limited announced its unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2026. The results were approved by the Board on November 6, 2026, accompanied by limited review reports from Deloitte Haskins & Sells. Detailed results are available on the company's website and the stock exchanges' portals.
Gland Pharma Limited
General / Other
Gland Pharma Limited has announced its unaudited consolidated and standalone financial results for the quarter and half year ending September 30, 2026, following approval by its Board of Directors on November 6, 2026.
The unaudited financial results were subjected to limited review by the company's statutory auditors, Deloitte Haskins & Sells.
These results are accessible to investors and the public on Gland Pharma’s official website as well as on the BSE and NSE stock exchange websites.
The announcement complies with Regulation 33 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency and timely dissemination of financial information.
No specific profit or loss figures were disclosed in the announcement; it serves primarily to notify availability and approval of the financial statements for the referenced reporting period.
Highlights
- Unaudited financial results for Q2 and H1 FY27 approved on November 6, 2026.
- Consolidated and standalone results reviewed by Deloitte Haskins & Sells.
- Results published on company and stock exchange websites for investor access.
- Compliance with SEBI regulations 33 and 47 for disclosure and publication.
Key Data Snapshot
What happened
- Gland Pharma’s Board approved the unaudited financial results for Q2 and half year ended September 30, 2026.
- The results include both consolidated and standalone financial statements.
Key details
- Limited review reports were obtained from the statutory auditors, Deloitte Haskins & Sells.
- Results are published on the company website and on BSE and NSE platforms.
- Announcement fulfills SEBI regulatory requirements for financial disclosures.
Regulatory and governance context
- Compliance with Regulation 33 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Ensures timely dissemination of unaudited financial results to stakeholders.
Highlights
- Unaudited financial results for Q2 and H1 FY27 approved on November 6, 2026.
- Consolidated and standalone results reviewed by Deloitte Haskins & Sells.
- Results published on company and stock exchange websites for investor access.
- Compliance with SEBI regulations 33 and 47 for disclosure and publication.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 33
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Regulation 47
Source Information
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Sobhagya Mercantile Ltd. Sets Extraordinary General Meeting for December 11, 2026, via Video Conferencing
Sobhagya Mercantile Limited has issued a public notice convening an Extraordinary General Meeting (EGM) scheduled for December 11, 2026, at 11:30 A.M. IST. The meeting will be conducted through video conferencing and other audio-visual means, with e-voting facilities provided to shareholders.
Read Full StoryAPL Apollo Tubes Denies Promoter Stake Sale Rumors Following Speculative News
APL Apollo Tubes Limited issued a clarification on November 20, 2026, denying any knowledge or communication regarding a proposed sale of promoter family shares amid speculative media reports.
Read Full StoryIndusInd Bank Conducts November 2026 Investor and Analyst Meetings in Chennai with Leading Asset Managers
On November 19, 2026, IndusInd Bank Limited conducted analyst and institutional investor meetings in Chennai, involving prominent asset management companies such as Franklin Templeton, Bandhan AMC, Axis AMC, and Motilal Oswal AMC. The bank clarified no unpublished price sensitive information was shared during these discussions.
Read Full Story